KRAS and squamous cell carcinoma: Mutations on EGFR, ERBB2 mutations and ROS1 fusions were found in patients diagnosed with AdKs, whereas KRAS, PIK3CA and TP53 mutations were detected in AdK as well as in squamous carcinoma (SqK) patients.